The stock of Diversified Healthcare Trust (NASDAQ:DHC) decreased by -$0.02 on Tuesday to finish at $2.31, down -0.86 percent. The last five days have seen an average of 2,772,940 shares of common stock traded. 21 times new highs were reached in the current year, with a gain of $1.66. The average number of shares traded over the last 20 days was 2,139,915, while the average volume over the last 50 days totaled 1,860,662.
DHC stock dropped -21.69% since last month. On 09/18/23, the company’s shares reached a one-month low of $2.19. The stock touched a high of $3.30 on 08/08/23, after rallying from a low of $0.61 in 52 weeks. The price of DHC stock has risen by 257.14% or $1.66 this year, reaching a new high 21 times. Still, the stock price is down -30.00% from the 52-week high.
Insider Transactions
DHC stock investors should be aware that Diversified Healthcare Trust (DHC) stock had its last reported insider trading activity 98 days ago on Jun 14. On Jun 14, Director PORTNOY ADAM D. acquired 2,000,000 shares at $3.07 each. This transaction resulted in the insider spending $6,132,600. On Jun 13, PORTNOY ADAM D. added 1,992,259 shares at a price of US$3.03. After the transaction, the insider now owns 21,250,019 shares. Director PORTNOY ADAM D. had earlier bought 2,011,256 shares on Jun 12 for $2.87 a share. The transaction was completed for $5,778,540.
Valuation Metrics
Beta for the stock is 1.87. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 0.45, the price-to-book (PB) ratio of 0.22.
Company paid $0.01 per share in dividends, remained unchanged from $0.01 last year. A $0.14 dividend decrease was reported on Thursday April 2 2020.
Financial Health
The company’s long-term debt to equity ratio for the quarter ending June 29 is 1.11, and the total debt to equity ratio is 1.11. As far as profitability goes, gross margin for the trailing twelve months is 15.20% percent. Diversified Healthcare Trust’s operating margin stood at -7.60% for the same period. Based on annual data, it had gross profit of -$93.82 million and revenue of $1.28 billion.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. DHC’s return on assets (ROA) during the last 12 months has been -4.70%. There was a -2.20% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was -10.40%.
Earnings Surprise
According to Diversified Healthcare Trust’s quarterly financial report for the quarter that ended June 29. A higher net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $346.22 million, while revenues rose by 9.59% to $346.03 million. It was predicted that Diversified Healthcare Trust’s quarterly earnings would be -$0.3, but it ended up being -$0.23, beating the consensus by -30.40%. EBITDA was $37.64 million for the quarter. At the end of Diversified Healthcare Trust’s most recent quarter ended June 29, its total debt was $2.81 billion. Equity owned by shareholders amounts to $239.79 million.
Technical Picture
Here’s a quick look at Diversified Healthcare Trust’s (DHC) price momentum from a technical perspective. As of 19 September, the RSI 9-day stood at 38.81%, suggesting the stock is Neutral, with a 95.70% historical volatility rate.
The stochastic %K and %D were 15.10% and 20.47% respectively, while the average true range (ATR) was 0.19. Based on the 14-day stochastic reading of 14.63%, the RSI (14) reading is 41.49%. On the 9-day MACD Oscillator, the stock is at -0.02, and the 14-day reading is at -0.14.
Analyst Ratings
Diversified Healthcare Trust (NASDAQ: DHC) was downgraded by Wells Fargo to a an Underweight rating in its latest research report. The stock was previously rated as a an Equal weight. Analysts have assigned Diversified Healthcare Trust (DHC) an Hold rating. DHC is a stock that is recommended for selling by 0 brokerage firms, while 0 companies recommend holding. The stock is underweighted by 1 analyst. Among the analysts who rate the stock, 0 rates it overweight and 1 other recommend it as a buy.
What is DHC’s price target for the next 12 months?
The current consensus forecast for the stock is between $0.90 and $4.50, with a median target price of $2.70. In analyzing these forecasts, the average price target given by analysts for Diversified Healthcare Trust (DHC) is $2.70.
